Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Discover the latest development that may affect clinical practice and research in oncology during and after the pandemic.

Cytotoxic Therapy;  COVID-19 and Cancer;  Immunotherapy;  Thoracic Malignancies

Thoracic Cancer Mortality After COVID-19 Not Linked To Recent Systemic Therapy

From the World Conference on Lung Cancer 2022:
Around a fifth of patients with thoracic cancer die within 30 days of COVID-19 infection but the risk is not predicted by recent receipt of systematic treatment for their malignancy

COVID-19 and Cancer;  Radiation Oncology

Radiotherapy Delays Due To COVID-19 Reported

Restrictive measures to control the spread of COVID-19 have adverse effect on continuation of radiotherapy in patients with cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.